Hillstream BioPharma, Inc.
USD0.24
+0.01 (+5.66%)
CEO
Randy D. Milby MBA
IPO Date
2022-01-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.23
Prev. Close
$0.22
Day Low
$0.22
Day High
$0.24
52W Low
$0.17
52W High
$2.65
Market Cap
$0.00B
Volume
0.31M
| -0.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -102.1% | -85.1% | 0.00 | 6.03 | -0.0 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -152.8% | -126.7% | 0.00 | 5.84 | -0.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 64.8% | -488.7% | -0.46 | 0.14 | -11.8 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 63.9% | -805.5% | -0.50 | 0.11 | -16.5 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 72.2% | -2864.8% | -0.59 | 0.04 | -33.4 |
| -0.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -34.1% | -27.3% | 0.00 | 4.98 | -0.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -505.0% | -73.3% | 0.00 | 1.17 | -0.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 312.0% | -153.0% | 0.00 | 0.67 | -0.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -409.3% | -143.8% | 0.00 | 1.54 | -0.0 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -125.8% | -72.3% | 0.00 | 2.35 | -0.0 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -34.7% | -28.2% | 0.00 | 5.28 | -0.0 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -103.6% | -57.5% | 0.00 | 2.25 | -0.5 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -76.1% | -50.8% | 0.00 | 3.01 | -0.6 |